BackGoodRx Holdings Overview
stock.name

GoodRx Holdings Target Price

Analysts' 12-month price predictions for GDRX.

Share Price

$7.48

Average Target Price

$9.4025.7% upside

5 analysts in the last 4 months

High: $10 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-05-16BarclaysStephanie Davis$920.3% upsideOpen
2024-05-16Raymond JamesAaron Kessler$1033.7% upsideOpen
2024-04-10BOCOM International Holdings CompanyScott Schoenhaus$920.3% upsideOpen
2024-04-10KeyBancScott Schoenhaus$920.3% upsideOpen
2024-03-25Wells FargoStan Berenshteyn$1033.7% upsideOpen
2023-11-13Goldman SachsEric Sheridan$359.9% downsideOpen
2022-12-01Citigroup$76.4% downsideOpen
2022-08-09BarclaysSteve Valiquette$1373.8% upsideOpen
2022-06-07Robert W. BairdVikram Kesavabhotla$76.4% downsideOpen
2022-05-12Wells FargoStan Berenshteyn$920.3% upsideOpen
2022-03-01J.P. MorganDoug Anmuth$20167.4% upsideOpen
2022-03-01Goldman SachsEric Sheridan$30301.1% upsideOpen
2022-03-01Cowen & Co.Charles Rhyee$22194.1% upsideOpen
2022-03-01Bank of America SecuritiesJustin Post$28274.3% upsideOpen
2022-03-01Deutsche BankGeorge Hill$20167.4% upsideOpen
2021-12-21StephensScott Schoenhaus$45501.6% upsideOpen
2021-05-14CitigroupNicholas Jones CFA$53608.6% upsideOpen